Endocrinology, Vol 133, 2171-2176, Copyright © 1993 by Endocrine Society

ARTICLES

9-cis-retinoic acid regulates the expression of the muscle determination gene Myf5

G Carnac, O Albagli-Curiel, A Levin and A Bonnieu
Laboratoire de Differenciation Cellulaire et Croissance, INRA, Montpellier, France.

Myf5 is a member of the MyoD family, a set of four helix-loop-helix transcription factors that controls myogenic differentiation. The Myf5 gene has both in vivo and in vitro expression patterns consistent with an involvement in the first events of myogenesis, such as acquisition and/or maintenance of myogenic "determined" phenotype. To date, very little is known about the mechanism underlying the tight regulation of Myf5 expression. We report here that retinoic acid (RA) reduces the level of Myf5 message in both mouse C2 and rat L6 cell lines, probably at the transcriptional level, because Myf5 mRNA stability is not affected by RA. This repression is dose dependent, starting at 0.1 microM of all-trans RA, and is not abrogated by cycloheximide, suggesting a direct involvement of RA receptors in the control of Myf5 expression. Furthermore, we compared the efficiency of natural (all- trans RA and 9-cis RA) or synthetic (TTNPB) retinoids that differentially activate the two families of RA receptors, RA receptors and retinoid X-receptors (9-cis RA). As 9-cis RA is about 10 times more efficient than all-trans RA in repressing Myf5, whereas TTNPB, which preferentially activates RA receptors, is far less potent, our data provide evidence for an important role of ligand-bound retinoid X- receptors in the mediation of this inhibition.

This article has been cited by other articles:

				B. C. Villafuerte and E. N. Kaytor An Insulin-response Element-binding Protein That Ameliorates Hyperglycemia in Diabetes J. Biol. Chem., May 20, 2005; 280(20): 20010 - 20020. [Abstract] [Full Text] [PDF]

				D. Downie, C. Antipatis, M. I. Delday, C. A. Maltin, and A. A. Sneddon Moderate maternal vitamin A deficiency alters myogenic regulatory protein expression and perinatal organ growth in the rat Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2005; 288(1): R73 - R79. [Abstract] [Full Text] [PDF]

				T. Launay, A.-S. Armand, F. Charbonnier, J.-C. Mira, E. Donsez, C. L. Gallien, and C. Chanoine Expression and Neural Control of Myogenic Regulatory Factor Genes During Regeneration of Mouse Soleus J. Histochem. Cytochem., July 1, 2001; 49(7): 887 - 900. [Abstract] [Full Text] [PDF]

				Y.-J. Kim, S. Noguchi, Y. K. Hayashi, T. Tsukahara, T. Shimizu, and K. Arahata The product of an oculopharyngeal muscular dystrophy gene, poly(A)-binding protein 2, interacts with SKIP and stimulates muscle-specific gene expression Hum. Mol. Genet., May 1, 2001; 10(11): 1129 - 1139. [Abstract] [Full Text] [PDF]

				F Aurade, C. Pfarr, C Lindon, A Garcia, M Primig, D Montarras, and C Pinset The glucocorticoid receptor and AP-1 are involved in a positive regulation of the muscle regulatory gene myf5 in cultured myoblasts J. Cell Sci., January 11, 1997; 110(22): 2771 - 2779. [Abstract] [PDF]

				D. Montarras, F. Aurade, T. Johnson, J. IIan, F. Gros, and C. Pinset Autonomous differentiation in the mouse myogenic cell line, C2, involves a mutual positive control between insulin-like growth factor II and MyoD, operating as early as at the myoblast stage J. Cell Sci., March 1, 1996; 109(3): 551 - 560. [Abstract] [PDF]